Current concepts in neuromuscular transmission

British Journal of Anaesthesia

Volumn 103, Issue 1, 2009, Pages 108-114

  Fagerlund, M J ^a   Eriksson, L I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylcholine; Neuromuscular block; Neuromuscular transmission, synapse; Receptors, cholinergic; Receptors, postsynaptic; Receptors, presynaptic

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; NICOTINIC RECEPTOR;

DRUG MECHANISM; ELECTRIC ACTIVITY; HUMAN; INTENSIVE CARE; MUSCLE CONTRACTILITY; NEUROMUSCULAR SYSTEM; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; REVIEW; DRUG EFFECT; METHODOLOGY; MONITORING; NEUROMUSCULAR SYNAPSE; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

HUMANS; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION;

EID: 67650738726     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep150     Document Type: Review

References (41)

1. Bowman WC. Block by depolarization. Acta Anaesthesiol Scand 1994; 38: 529-32
2. Bowman WC, Prior C, Marshall IG. Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci 1990; 604: 69-81
3. Chiodini F, Charpantier E, Muller D, Tassonyi E, Fuchs-Buder T, Bertrand D. Blockade and activation of the human neuronal nic-otinic acetylcholine receptors by atracurium and laudanosine. Anesthesiology 2001; 94: 643-51
4. Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science 2002; 298: 770-6
5. Corriveau RA, Romano SJ, Conroy WG, Oliva L, Berg DK. Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development. J Neurosci 1995; 15: 1372-83
6. Eriksson LI. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand 1996; 40: 520-3
7. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992; 36: 710-5
8. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43
9. Fischer U, Reinhardt S, Albuquerque EX, Maelicke A. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur J Neurosci 1999; 11: 2856-64
10. Garland CM, Foreman RC, Chad JE, Holden-Dye L, Walker RJ. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. Eur J Pharmacol 1998; 357: 83-92
11. Goldman D, Brenner HR, Heinemann S. Acetylcholine receptor alpha-, beta-, gamma-, and delta-subunit mRNA levels are regulated by muscle activity. Neuron 1988; 1: 329-33
12. Heidelberger R. Neuroscience: sensors and synchronicity. Nature 2007; 450: 623-5
13. Henry MD, Campbell KP. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996; 8: 625-31
14. Jonsson M, Dabrowski MA, Eriksson LI. Pharmacological characteristics of the inhibition of non-depolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology 2009; 110: 1244-52
15. Jonsson M, Dabrowski M, Gurley DA, et al. Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology 2006; 104: 724-33
16. Jonsson M, Gurley D, Dabrowski M, Larsson O, Johnson EC, Eriksson LI. Distinct pharmacological properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors - a possible mechanism behind the train-of-four fade. Anesthesiology 2006; 105: 521-33
17. Jonsson M, Kim C, Yamamoto Y, Runold M, Lindahl SG, Eriksson LI. Atracurium and vecuronium block nicotine-induced carotid body chemoreceptor responses. Acta Anaesthesiol Scand 2002; 46: 488-94
18. Jonsson M, Wyon N, Lindahl SG, Fredholm BB, Eriksson LI. Neuromuscular blocking agents block carotid body neuronal nic-otinic acetylcholine receptors. Eur J Pharmacol 2004; 497: 173-80
19. Koirala S, Reddy LV, Ko CP. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol 2003; 32: 987-1002
20. Langley JN. On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol 1905; 33: 374-413
21. Lin W, Sanchez HB, Deerinck T, Morris JK, Ellisman M, Lee KF. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Natl Acad Sci USA 2000; 97: 1299-304
22. Luetje CW, Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 1991; 11: 837-45
23. Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-69
24. Mishina M, Takai T, Imoto K, et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986; 321: 406-11
25. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP. Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch. Dev Biol 1996; 179: 223-38
26. Newsom-Davis J. The emerging diversity of neuromuscular junction disorders. Acta Myol 2007; 26: 5-10
27. Rizzoli SO, Betz WJ. The structural organization of the readily releasable pool of synaptic vesicles. Science 2004; 303: 2037-9
28. Rochon D, Rousse I, Robitaille R. Synapse-glia interactions at the mammalian neuromuscular junction. J Neurosci 2001; 21: 3819-29
29. Romano SJ, Pugh PC, McIntosh JM, Berg DK. Neuronal-type acetylcholine receptors and regulation of alpha 7 gene expression in vertebrate skeletal muscle. J Neurobiol 1997; 32: 69-80
30. Ryten M, Koshi R, Knight GE, et al. Abnormalities in neuromus-cular junction structure and skeletal muscle function in mice lacking the P2X2 nucleotide receptor. Neuroscience 2007; 148: 700-11
31. Shirahata M, Balbir A, Otsubo T, Fitzgerald RS. Role of acetyl-choline in neurotransmission of the carotid body. Respir Physiol Neurobiol 2007; 157: 93-105
32. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004; 27: 509-47
33. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84
34. Tracey KJ. Physiology and immunology of the cholinergic antiin-flammatory pathway. J Clin Invest 2007; 117: 289-96
35. Tsuneki H, Kimura I, Dezaki K, Kimura M, Sala C, Fumagalli G. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 1995; 196: 13-6
36. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-3
37. Vizi ES, Lendvai B. Side effects of nondepolarizing muscle relax-ants: relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 1997; 73: 75-89
38. Vulpian E. Lecon sur la physiologie generale et compare du systeme nerveux. Paris: Balliere, 1866
39. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8
40. Willis B, Eubanks LM, Dickerson TJ, Janda KD. The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison. Angew Chem Int Ed Engl 2008; 47: 8360-79
41. Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI. Carotid body chemoreceptor function is impaired by vecuronium during hypoxia. Anesthesiology 1998; 89: 1471-9